White biotechnology: ready to partner and invest in.
It needs three factors to build an industry: market demand, product vision and capital. White biotechnology already produces high volume products such as feed additive amino acids and specialty products like enzymes for enantioselective biocatalysis. It serves large and diverse markets in the nutrition, wellness, pharmaceutical, agricultural and chemical industry. The total volume adds up to $ 50 billion worldwide. In spite of its proven track record, white biotechnology so far did not attract as much capital as red and even green biotechnology. However, the latest finance indicators confirm the continuously growing attractiveness of investment opportunities in white biotechnology. This article discusses white biotechnology's position and potential in the finance market and success factors.
Kircher
Manfred
M
Degussa AG, Creavis Business Venture, Hanau, Germany. manfred.kircher@degussa.com
D001709:Biotechnology / Q000191:economics* / Q000639:trends; D002202:Capital Financing / Q000191:economics* / Q000639:trends; D003247:Conservation of Natural Resources / Q000191:economics* / Q000639:trends; D005062:European Union; D007221:Industry / Q000191:economics* / Q000639:trends; D007449:Investments / Q000191:economics* / Q000639:trends; D014481:United States